Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,258,724 papers from all fields of science
Search
Sign In
Create Free Account
JAK2 NP_004963.1:p.V617X
Known as:
JAK2 NP_004963.1:p.Val617Xxx
, JAK2 p.V617
, NP_004963.1:p.Val617Xxx
Expand
A change in the amino acid residue at position 617 in the tyrosine-protein kinase JAK2 protein where valine has been replaced by another amino acid…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
JAK2 Gene Mutation
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Next generation sequencing redefines a triple negative essential thrombocythaemia as double‐positive with rare mutations on JAK2 V617 and MPL W515 hotspots
Annaëlle Beucher
,
M. Dib
,
+10 authors
D. Luque Paz
British Journal of Haematology
2019
Corpus ID: 155091589
Badaloo, A., Jackson, A.A. & Jahoor, F. (1989) Whole body protein turnover and resting metabolic rate in homozygous sickle cell…
Expand
2015
2015
Evolving Therapeutic Options for Polycythemia Vera: Perspectives of the Canadian Myeloproliferative Neoplasms Group.
S. Sirhan
,
L. Busque
,
+10 authors
Vikas Gupta
Clinical Lymphoma, Myeloma & Leukemia
2015
Corpus ID: 24868739
2013
2013
Lack of JAK2 activating non-synonymous mutations in diffuse large B-cell tumors: JAK2 deregulation still unexplained
T. Witzig
,
T. Price-Troska
,
M. Stenson
,
Mamta Gupta
Leukemia and Lymphoma
2013
Corpus ID: 13347705
Emerging evidence indicates that JAK2-STAT3 signaling is frequent in DLBCL cell lines and half of the activated B cell –like (ABC…
Expand
2010
2010
Methylation of TET2, CBL and CEBPA in Ph-negative myeloproliferative neoplasms
C. Chim
,
T. S. Wan
,
T. Fung
,
Kit Fai Wong
Journal of Clinical Pathology
2010
Corpus ID: 26343427
A loss-of-function mutation of TET2, CBL and CEBPA has been implicated in the pathogenesis or leukaemic transformation of…
Expand
Review
2008
Review
2008
An update on the platelet dysfunction in chronic myeloproliferative syndromes.
A. Vlădăreanu
,
C. Ciufu
,
H. Bumbea
,
M. Onisâi
,
S. Aramă
Romanian journal of internal medicine = Revue…
2008
Corpus ID: 5209734
The thrombotic and hemorrhagic diathesis represents a frequent complication in myeloproliferative disorders (CMPD). They are…
Expand
2007
2007
Detection of Three Different MPLW515 Mutations in 10.1% of All JAK2 V617 Unmutated ET and 9.3% of All JAK2 V617F Unmutated OMF: A Study of 387 Patients.
S. Schnittger
,
C. Haferlach
,
+12 authors
T. Haferlach
2007
Corpus ID: 78723252
Recently MPLW515 mutations have been reported in osteomyelofibrosis (OMF) and essential thrombocythemia (ET). To further evaluate…
Expand
2007
2007
Transient jets in V617 Sagittarii
J. Steiner
,
A. S. Oliveira
,
C. Torres
,
A. Damineli
2007
Corpus ID: 7317941
Context. Some of the luminous Compact Binary Supersoft X-Ray sources (CBSS) have shown indications of jets, also called…
Expand
2007
2007
Incidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders
S. Langabeer
,
F. Ní Áinle
,
E. Conneally
,
M. Lawler
Irish Journal of Medical Science
2007
Corpus ID: 42118513
BackgroundThe chronic myeloproliferative disorders (MPD) are clonal haemopoietic stem cell disorders.AimsThe incidence of JAK2…
Expand
Highly Cited
2006
Highly Cited
2006
High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis
Aline Renneville
,
B. Quesnel
,
+8 authors
C. Preudhomme
Leukemia
2006
Corpus ID: 37587268
High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis
2006
2006
MPL W515 and JAK2 V617 mutation analysis in patients with refractory anemia with ringed sideroblasts and an elevated platelet count.
D. Steensma
,
J. S. Caudill
,
A. Pardanani
,
R. Mcclure
,
T. Lasho
,
A. Tefferi
Haematologica
2006
Corpus ID: 43726791
Discovery of a constitutively activating point mutation of the Janus kinase 2 (JAK2) receptor-associated tyrosine kinase in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE